Remove www.fda.gov about-fda center-drug-evaluation-and-research-cder cders-framework-regulatory-advanced-manufacturing-evaluation-frame-initiative
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. McQueen Nina S.

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

It is incumbent for industry to modernize manufacturing processes to improve efficiency and increase confidence in quality assurance for the benefit of patients while introducing novel technology and modalities as the science advances. Representatives from regulatory authorities are also encouraged to complete the survey.

FDA 52